$13.36
0.191.44%
At close: -
$13.45
0.090.67%
After Hours: Dec 20, 4:07 PM EDT
Comments
Loading...
Myriad Genetics (NASDAQ:MYGN) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for Myriad Genetics (MYGN)?
The most recent guidance for Myriad Genetics (MYGN) was reported on November 7, 2024 for the full year 2024. The company provided earnings per share guidance in the range of $0.12 to $0.14, compared to the estimated EPS of $0.10. Additionally, Myriad Genetics forecasted revenue between $0.84B and $0.84B for the quarter.
Browse guidance and forecast on all stocks.